Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by signaling your brain to feel fuller longer and reducing hunger signals, leading many patients to lose 10-15% of their body weight over 68 weeks in clinical trials. The medication addresses the biological mechanisms driving appetite rather than relying on willpower alone. PlexusDx delivers compounded semaglutide from licensed pharmacies to support your personalized weight loss journey.
How Semaglutide Helps People Lose Weight
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that controls appetite and blood sugar. When you take semaglutide, it activates GLP-1 receptors in your brain's satiety center, making you feel satisfied with smaller portions and reducing cravings between meals. This mechanism shifts your relationship with food without requiring extreme dietary restriction.
The medication also slows gastric emptying—the rate at which your stomach releases food into your intestines. This extended sensation of fullness means you naturally eat less without constantly fighting hunger. Over time, this sustainable reduction in calorie intake leads to consistent weight loss rather than the rapid gain-and-loss cycle common with restrictive dieting.
Clinical Trial Results for Weight Loss with Semaglutide
The STEP clinical trials, which followed thousands of participants for 68 weeks, showed that semaglutide at the 2.4 mg dose resulted in an average weight loss of 14.9% of baseline body weight. Participants on the highest approved dose lost significantly more weight than those receiving placebo, with many maintaining their results through continued treatment. These results were sustained even after dosing was completed in extended follow-up periods.
Real-world data from clinical practice confirms these trial outcomes. Patients using semaglutide consistently report losing 15-22% of their starting weight when combining medication with moderate lifestyle modifications. Success rates improve when semaglutide is paired with personalized nutrition guidance and regular physical activity, creating a comprehensive approach to weight management.
Why Individual Responses to Semaglutide Vary
Not everyone loses weight at the same rate on semaglutide because genetic differences affect how your body responds to GLP-1 signaling. Your GLP1R gene variant, for example, influences the efficiency of semaglutide's action at the receptor level. The PlexusDx Precision Peptide Genetic Test identifies key variants including GLP1R rs6923761 to predict your medication sensitivity and optimize your treatment plan.
Additional genetic factors like MC4R and FTO variants shape your baseline appetite regulation and metabolism. Some patients experience appetite suppression within days, while others require 4-6 weeks to feel the full effect. Understanding your genetic profile helps PlexusDx clinicians adjust your starting dose and escalation timeline to match your body's unique response pattern, maximizing weight loss while minimizing side effects.
Getting Started with Semaglutide at PlexusDx
PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies starting at just $149 per month, with no insurance required and no membership fees. Your dose may need to go up as your body adjusts, but your price won't change—PlexusDx maintains the same monthly cost across all dose levels. The medication is HSA and FSA eligible, making it accessible for most patients.
After your first month of semaglutide treatment, you can add the PlexusDx Precision Peptide Genetic Test for $99 to map your 14 metabolic pathways and 49 peptide responses. This test reveals how your genetics influence weight loss, hunger hormones, and medication response, allowing your clinician to personalize your therapy. PlexusDx serves all 50 states with telehealth consultations and direct pharmacy shipping, removing barriers to treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose on semaglutide?
Clinical trials show average weight loss of 14.9% of baseline weight over 68 weeks, with some patients losing up to 22% when combined with lifestyle changes. Your individual results depend on your starting weight, genetics, adherence, and lifestyle modifications. PlexusDx's Precision Peptide Genetic Test can help predict your personalized weight loss potential based on your GLP1R and other appetite-related variants.
How long does it take to see weight loss results from semaglutide?
Most patients begin noticing reduced appetite within 2-4 weeks of starting semaglutide, with measurable weight loss appearing around week 4-8. Continued weight loss typically accelerates as doses are increased over the titration period. Maximum results are usually seen around 16-20 weeks of consistent treatment at therapeutic doses.
What is the cost of semaglutide at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, membership fees, or flat per-compound pricing increases. Your dose may need to go up as treatment progresses, but your price remains the same. The medication is HSA and FSA eligible, and PlexusDx serves all 50 states with free telehealth access.
Are there side effects from semaglutide weight loss treatment?
Common side effects include mild nausea, constipation, and appetite loss, which typically decrease within 1-2 weeks as your body adjusts. Serious side effects are rare but can include pancreatitis or thyroid concerns in susceptible individuals. PlexusDx clinicians monitor your response and adjust your treatment plan to minimize discomfort while maintaining weight loss effectiveness.
How does the PlexusDx Precision Peptide Genetic Test improve weight loss results?
The test identifies your unique genetic variants in GLP1R, GIPR, MC4R, and FTO genes that directly influence hunger hormones and medication response. This allows PlexusDx to personalize your starting dose, escalation schedule, and potentially recommend complementary peptides. Patients with genetic insights achieve more predictable weight loss and experience fewer dose adjustments.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Does Compounded Semaglutide Do? Exploring Its Role in Weight Loss Management
Understanding the Shelf Life of Compounded Tirzepatide: Essential Insights for Safe Use